» Articles » PMID: 37441502

Electroacupuncture Treatment Ameliorates Metabolic Disorders in Obese ZDF Rats by Regulating Liver Energy Metabolism and Gut Microbiota

Overview
Specialty Endocrinology
Date 2023 Jul 13
PMID 37441502
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic disorders represent a major therapeutic challenge to public health worldwide due to their dramatically increasing prevalence. Acupuncture is widely used as adjuvant therapy for multiple metabolic diseases. However, detailed biological interpretation of the acupuncture stimulations is still limited. The gut and the liver are intrinsically connected and related to metabolic function. Microbial metabolites might affect the gut-liver axis through multiple mechanisms. Liver metabolomics and 16S rRNA sequencing were used to explore the specific mechanism of electroacupuncture in treating ZDF rats in this study. Electroacupuncture effectively improved glycolipid metabolism disorders of the ZDF rats. Histopathology confirmed that electroacupuncture improved diffuse hepatic steatosis and hepatocyte vacuolation, and promoted glycogen accumulation in the liver. The treatment significantly improved microbial diversity and richness and upregulated beneficial bacteria that maintain intestinal epithelial homeostasis and decreased bacteria with detrimental metabolic features on host metabolism. Liver metabolomics showed that the main effects of electroacupuncture include reducing the carbon flow and intermediate products in the TCA cycle, regulating the metabolism of various amino acids, and inhibiting hepatic glucose output and lipogenesis. The gut-liver axis correlation analysis showed a strong correlation between the liver metabolites and the gut microbiota, especially allantoin and . Electroacupuncture treatment can improve abnormal energy metabolism by reducing oxidative stress, ectopic fat deposition, and altering metabolic fluxes. Our results will help us to further understand the specific mechanism of electroacupuncture in the treatment of metabolic diseases.

Citing Articles

Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats.

Yue Z, Xiang W, Duping D, Yuanyuan G, Xuanyi C, Juan L Front Microbiol. 2025; 15():1436911.

PMID: 39834366 PMC: 11743489. DOI: 10.3389/fmicb.2024.1436911.


"Adjusting internal organs and dredging channelon" electroacupuncture glycolipid metabolism disorders in NAFLD mice by mediating the AMPK/ACC signaling pathway.

Jia X, Li M, Zhang W, Guo Y, Xue F, Ma S Diabetol Metab Syndr. 2024; 16(1):173.

PMID: 39054547 PMC: 11271196. DOI: 10.1186/s13098-024-01416-7.


Acupuncture influences multiple diseases by regulating gut microbiota.

Xu H, Luo Y, Li Q, Zhu H Front Cell Infect Microbiol. 2024; 14:1371543.

PMID: 39040602 PMC: 11260648. DOI: 10.3389/fcimb.2024.1371543.


Osteoprotegerin mediates adipogenesis in obesity.

Lyu Z, Chan Y, Lu Y, Fung Lam T, Wu X, Wu J J Adv Res. 2024; 62:245-255.

PMID: 38906326 PMC: 11331166. DOI: 10.1016/j.jare.2024.06.018.

References
1.
Hyotylainen T, Jerby L, Petaja E, Mattila I, Jantti S, Auvinen P . Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat Commun. 2016; 7:8994. PMC: 4742839. DOI: 10.1038/ncomms9994. View

2.
Raza H, John A, Howarth F . Increased metabolic stress in Zucker diabetic fatty rat kidney and pancreas. Cell Physiol Biochem. 2013; 32(6):1610-20. DOI: 10.1159/000356597. View

3.
Pereira F, Wasmund K, Cobankovic I, Jehmlich N, Herbold C, Soo Lee K . Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. Nat Commun. 2020; 11(1):5104. PMC: 7547075. DOI: 10.1038/s41467-020-18928-1. View

4.
Lu L, Zhang Y, Tang X, Ge S, Wen H, Zeng J . Evidence on acupuncture therapies is underused in clinical practice and health policy. BMJ. 2022; 376:e067475. PMC: 8868048. DOI: 10.1136/bmj-2021-067475. View

5.
Miao Z, Chen G, Huo S, Fu Y, Wu M, Xu F . Interaction of n-3 polyunsaturated fatty acids with host CD36 genetic variant for gut microbiome and blood lipids in human cohorts. Clin Nutr. 2022; 41(8):1724-1734. DOI: 10.1016/j.clnu.2022.05.021. View